rs34797451

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_003835.4(RGS9):​c.1502G>A​(p.Arg501His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.017 in 1,613,616 control chromosomes in the GnomAD database, including 292 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R501L) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.011 ( 15 hom., cov: 32)
Exomes 𝑓: 0.018 ( 277 hom. )

Consequence

RGS9
NM_003835.4 missense

Scores

2
2
11

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 0.604

Publications

10 publications found
Variant links:
Genes affected
RGS9 (HGNC:10004): (regulator of G protein signaling 9) This gene encodes a member of the RGS family of GTPase activating proteins that function in various signaling pathways by accelerating the deactivation of G proteins. This protein is anchored to photoreceptor membranes in retinal cells and deactivates G proteins in the rod and cone phototransduction cascades. Mutations in this gene result in bradyopsia. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Sep 2009]
RGS9 Gene-Disease associations (from GenCC):
  • prolonged electroretinal response suppression 1
    Inheritance: AR Classification: DEFINITIVE Submitted by: G2P
  • bradyopsia
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, ClinGen, Labcorp Genetics (formerly Invitae), PanelApp Australia

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.004187554).
BP6
Variant 17-65225096-G-A is Benign according to our data. Variant chr17-65225096-G-A is described in ClinVar as Benign. ClinVar VariationId is 94379.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0114 (1735/152086) while in subpopulation NFE AF = 0.0195 (1327/67948). AF 95% confidence interval is 0.0187. There are 15 homozygotes in GnomAd4. There are 791 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 15 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RGS9NM_003835.4 linkc.1502G>A p.Arg501His missense_variant Exon 18 of 19 ENST00000262406.10 NP_003826.2
RGS9NM_001081955.3 linkc.1493G>A p.Arg498His missense_variant Exon 18 of 19 NP_001075424.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RGS9ENST00000262406.10 linkc.1502G>A p.Arg501His missense_variant Exon 18 of 19 1 NM_003835.4 ENSP00000262406.9

Frequencies

GnomAD3 genomes
AF:
0.0114
AC:
1735
AN:
151970
Hom.:
15
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00368
Gnomad AMI
AF:
0.00549
Gnomad AMR
AF:
0.00858
Gnomad ASJ
AF:
0.00115
Gnomad EAS
AF:
0.00116
Gnomad SAS
AF:
0.00104
Gnomad FIN
AF:
0.00782
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0195
Gnomad OTH
AF:
0.0105
GnomAD2 exomes
AF:
0.0107
AC:
2668
AN:
249178
AF XY:
0.0104
show subpopulations
Gnomad AFR exome
AF:
0.00329
Gnomad AMR exome
AF:
0.00559
Gnomad ASJ exome
AF:
0.000795
Gnomad EAS exome
AF:
0.000723
Gnomad FIN exome
AF:
0.00879
Gnomad NFE exome
AF:
0.0185
Gnomad OTH exome
AF:
0.00941
GnomAD4 exome
AF:
0.0175
AC:
25623
AN:
1461530
Hom.:
277
Cov.:
32
AF XY:
0.0169
AC XY:
12288
AN XY:
727092
show subpopulations
African (AFR)
AF:
0.00254
AC:
85
AN:
33480
American (AMR)
AF:
0.00539
AC:
241
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.000727
AC:
19
AN:
26132
East Asian (EAS)
AF:
0.000302
AC:
12
AN:
39700
South Asian (SAS)
AF:
0.00184
AC:
159
AN:
86258
European-Finnish (FIN)
AF:
0.00879
AC:
467
AN:
53108
Middle Eastern (MID)
AF:
0.000173
AC:
1
AN:
5766
European-Non Finnish (NFE)
AF:
0.0214
AC:
23805
AN:
1111966
Other (OTH)
AF:
0.0138
AC:
834
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.469
Heterozygous variant carriers
0
1613
3226
4838
6451
8064
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
896
1792
2688
3584
4480
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0114
AC:
1735
AN:
152086
Hom.:
15
Cov.:
32
AF XY:
0.0106
AC XY:
791
AN XY:
74342
show subpopulations
African (AFR)
AF:
0.00366
AC:
152
AN:
41480
American (AMR)
AF:
0.00857
AC:
131
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.00115
AC:
4
AN:
3464
East Asian (EAS)
AF:
0.00116
AC:
6
AN:
5178
South Asian (SAS)
AF:
0.00104
AC:
5
AN:
4812
European-Finnish (FIN)
AF:
0.00782
AC:
83
AN:
10608
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0195
AC:
1327
AN:
67948
Other (OTH)
AF:
0.0104
AC:
22
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.488
Heterozygous variant carriers
0
81
162
244
325
406
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
22
44
66
88
110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0159
Hom.:
47
Bravo
AF:
0.0106
TwinsUK
AF:
0.0194
AC:
72
ESP6500AA
AF:
0.00466
AC:
19
ESP6500EA
AF:
0.0181
AC:
152
ExAC
AF:
0.0108
AC:
1311
Asia WGS
AF:
0.00115
AC:
4
AN:
3478
EpiCase
AF:
0.0149
EpiControl
AF:
0.0170

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

not specified Benign:1
Aug 01, 2013
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.090
BayesDel_addAF
Benign
-0.54
T
BayesDel_noAF
Benign
-0.53
CADD
Benign
23
DANN
Uncertain
1.0
DEOGEN2
Benign
0.0067
T;.;.;T
Eigen
Benign
0.027
Eigen_PC
Benign
0.12
LIST_S2
Benign
0.85
T;T;T;T
MetaRNN
Benign
0.0042
T;T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.0
.;.;.;L
PhyloP100
0.60
PrimateAI
Uncertain
0.51
T
PROVEAN
Benign
0.0
.;.;N;N
Sift
Pathogenic
0.0
.;.;D;D
Sift4G
Pathogenic
0.0
.;D;D;D
Vest4
0.0
ClinPred
0.019
T
GERP RS
3.9
Varity_R
0.15
gMVP
0.43
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.040
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs34797451; hg19: chr17-63221214; COSMIC: COSV99068753; API